Rationally co-targeting divergent pathways in KRAS wild-type colorectal cancers by CANscript technology reveals tumor dependence on Notch and Erbb2-Reference-Cited by-同舟云学术

Rationally co-targeting divergent pathways in KRAS wild-type colorectal cancers by CANscript technology reveals tumor dependence on Notch and Erbb2

Published:2017-05-04 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Brijwani Nilesh,Jain Misti,Dhandapani Muthu,Zahed Farrah,Mukhopadhyay Pragnashree,Biswas Manjusha,Khatri Deepak,Radhakrishna Vinod D.,Majumder Biswanath,Radhakrishnan Padhma,Thiyagarajan Saravanan

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-01566-x.pdf

Reference66 articles.

1. Venook, A. P. Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma. Cancer 103, 2435–2446, doi: 10.1002/cncr.21123 (2005).

2. Baselga, J. The EGFR as a target for anticancer therapy–focus on cetuximab. Eur. J. Cancer 37(Suppl 4), S16–22, doi: 10.1016/S0959-8049(01)00233-7 (2001).

3. Lu, Y. et al. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer. Cancer. Biomark 11, 219–226, doi: 10.3233/CBM-2012-00282 (2012).

4. Cunningham, D. et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N. Engl. J. Med. 351, 337–345, doi: 10.1056/NEJMoa033025 (2004).

5. Schrag, D. The price tag on progress–chemotherapy for colorectal cancer. N. Engl. J. Med. 351, 317–319, doi: 10.1056/NEJMp048143 (2004).

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mismatch repair-proficient tumor footprints in the sands of immune desert: mechanistic constraints and precision platforms;Frontiers in Immunology;2024-07-19

2. Advancements in 3D In Vitro Models for Colorectal Cancer;Advanced Science;2024-07-04

3. Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells;British Journal of Cancer;2024-03-11

4. Use of patient-derived explants as a preclinical model for precision medicine in colorectal cancer: A scoping review;Langenbeck's Archives of Surgery;2023-10-10

5. Novel Ex Vivo Models of Epithelial Ovarian Cancer: The Future of Biomarker and Therapeutic Research;Frontiers in Oncology;2022-03-25